Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

198 Press Releases
DateTitleCompany
23 May 17 Action on Fistula to transform 4,500 lives by 2020 Astellas Pharma Europe
22 May 17 Astellas Named 2017 When Work Works Honoree by the Society for Human Resource Management Astellas ,
Published by
PharmiWeb.com
22 May 17 Astellas Announces Oncology Portfolio Updates Astellas ,
Published by
PharmiWeb.com
22 May 17 Astellas Announces Record Number of Abstracts Highlighting Breadth and Depth of Oncology Portfolio Data to be Presented at 2017 ASCO Annual Meeting Astellas ,
Published by
PharmiWeb.com
27 Apr 17 Astellas To Present on Challenges to Health Innovation at Milken Institute Global Conference Astellas,
Published by
PR Newswire
24 Apr 17 Use of Extended-Pulsed Regimen with DIFICLIR[TM] (fidaxomicin) is More Effective Than Standard vancomycin in Achieving Sustained Cure of Clostridium difficile Infection (CDI) and Preventing Recurrence[1] Astellas Pharma EMEA,
Published by
PR Newswire
24 Apr 17 Use of Extended-Pulsed Regimen with DIFICLIR[TM] (fidaxomicin) is More Effective Than Standard vancomycin in Achieving Sustained Cure of Clostridium difficile Infection (CDI) and Preventing Recurrence[1] Astellas Pharma EMEA,
Published by
PR Newswire
21 Apr 17 New Study Reveals the Impact of Clostridium difficile Infection (CDI) on the Health Service is Equivalent to an Additional 10,670 Bed Days a Year Astellas Pharma EMEA,
Published by
PR Newswire
31 Mar 17 Astellas Announces New President of Astellas US Technologies, Inc. Astellas,
Published by
PR Newswire
08 Feb 17 Astellas Names Linda Friedman General Counsel for Worldwide Legal Organization and Executive Committee Member Astellas,
Published by
PR Newswire
31 Jan 17 Astellas Reports the First Nine Months Financial Results of FY2016 Astellas Pharma Inc.,
Published by
Business Wire
30 Jan 17 Astellas and Ironwood Report Positive Top-Line Results from Phase III Linaclotide Trial for Patients with Chronic Constipation Conducted in Japan Ironwood Pharmaceuticals, Inc. & Astellas Pharma Inc.,
Published by
Business Wire
27 Jan 17 Over 2,000 women's lives transformed by Action on Fistula Astellas Pharma EMEA
26 Jan 17 OVER 2,000 WOMENS LIVES TRANSFORMED BY ACTION ON FISTULA Astellas Pharma EMEA
18 Jan 17 Astellas Announces Participation in Access Accelerated Astellas Pharma Inc.,
Published by
PR Newswire
21 Dec 16 Astellas Completes Acquisition of Ganymed Pharmaceuticals Astellas Pharma Inc.,
Published by
PR Newswire
08 Dec 16 Astellas Research & Development Meeting Highlights Astellas Pharma Inc.,
Published by
Business Wire
02 Dec 16 Astellas Renews Commitment with CUA-CUOG to Advance Uro-oncology Research in Canada Astellas Pharma Canada, Inc.,
Published by
PR Newswire
30 Oct 16 Astellas to Acquire Ganymed Pharmaceuticals Astellas ,
Published by
PharmiWeb.com
10 Nov 16 Astellas Partners with the Quebec Urological Association Foundation to Advance Urology Research Astellas Pharma Canada, Inc.,
Published by
PR Newswire
27 Oct 16 Astellas and Donate Life America Attempt to Achieve GUINNESS WORLD RECORDS™ Title for Organ Donor Registrations Astellas,
Published by
PR Newswire
02 Nov 16 Astellas Establishes Patient Experience Organization in the Americas Astellas,
Published by
PR Newswire
11 Oct 16 Astellas Oncology Announces Winning C3 Prize™ Ideas in Virtual Reality, Online Patient Support and Fatigue-Reducing Light Therapy to Change Cancer Care Astellas,
Published by
PR Newswire
30 Sep 16 More than 600 Astellas employees to give back to local communities across the U.S. and Brazil for Changing Tomorrow Day - the company's 7th annual global day of service Astellas,
Published by
PR Newswire
30 Sep 16 More than 600 Astellas employees to give back to local communities across the U.S. and Brazil for Changing Tomorrow Day - the company's 7th annual global day of service Astellas ,
Published by
PharmiWeb.com
09 Oct 16 New Data Presented at ESMO 2016 Further Demonstrates XTANDITM? (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo Astellas Pharma Europe Ltd.,
Published by
Business Wire
14 Oct 16 World Anti-Doping Agency and Astellas Announce Global Initiative to Prevent Misuse and Abuse of Medicines for Doping in Sports Astellas Pharma Canada, Inc.,
Published by
PR Newswire
24 Oct 16 FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer Astellas Pharma ,
Published by
PharmiWeb.com
17 Nov 16 Astellas Oncology Announces New Data in Acute Myeloid Leukemia to be Presented at the 2016 ASH Annual Meeting Astellas,
Published by
PR Newswire
18 Nov 16 Astellas Extends Commitment with the Canadian Urological Association to Advance Research in Canada Astellas Pharma Canada, Inc.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.